American International Group, Inc. Geron Corp Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Geron Corp stock. As of the latest transaction made, American International Group, Inc. holds 252,495 shares of GERN stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

252,495

Previous 254,663 0.85%

Holding current value

$1.07 Million

Previous $537,000 55.12%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.75 - $3.44 $3,794 - $7,457	-2,168 Reduced 0.85%	252,495 $833,000
Q4 2023 Feb 13, 2024	BUY	$1.74 - $2.31 $10,654 - $14,144	6,123 Added 2.46%	254,663 $537,000
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $18,646 - $28,985	8,837 Added 3.69%	248,540 $526,000
Q2 2023 Aug 04, 2023	BUY	$1.97 - $3.69 $65,252 - $122,223	33,123 Added 16.03%	239,703 $769,000
Q1 2023 May 12, 2023	BUY	$2.14 - $3.4 $74,371 - $118,160	34,753 Added 20.23%	206,580 $448,000

Q4 2022 Feb 10, 2023	BUY	$2.03 - $2.42 $2,561 - $3,054	1,262 Added 0.74%	171,827 $415,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $4,023 - $7,082	2,409 Added 1.43%	170,565 $399,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $1.65 $20,041 - $27,789	16,842 Added 11.13%	168,156 $261,000
Q1 2022 May 13, 2022	SELL	$0.99 - $1.6 $10,544 - $17,041	-10,651 Reduced 6.58%	151,314 $206,000
Q4 2021 Feb 11, 2022	SELL	$1.22 - $1.72 $3,751 - $5,289	-3,075 Reduced 1.86%	161,965 $198,000
Q3 2021 Nov 12, 2021	SELL	$1.2 - $1.5 $4,705 - $5,881	-3,921 Reduced 2.32%	165,040 $226,000
Q2 2021 Aug 13, 2021	BUY	$1.25 - $1.83 $1,895 - $2,774	1,516 Added 0.91%	168,961 $238,000
Q1 2021 May 07, 2021	BUY	$1.52 - $2.1 $671 - $928	442 Added 0.26%	167,445 $265,000
Q4 2020 Feb 12, 2021	SELL	$1.55 - $2.05 $7,427 - $9,823	-4,792 Reduced 2.79%	167,003 $266,000
Q3 2020 Nov 04, 2020	BUY	$1.59 - $2.19 $92,865 - $127,909	58,406 Added 51.51%	171,795 $299,000
Q2 2020 Aug 12, 2020	BUY	$1.05 - $2.18 $3,898 - $8,094	3,713 Added 3.39%	113,389 $247,000
Q1 2020 May 04, 2020	SELL	$0.89 - $1.49 $5,639 - $9,440	-6,336 Reduced 5.46%	109,676 $131,000
Q4 2019 Feb 05, 2020	BUY	$1.27 - $1.54 $7,204 - $8,736	5,673 Added 5.14%	116,012 $158,000
Q3 2019 Nov 08, 2019	BUY	$1.15 - $1.59 $409 - $566	356 Added 0.32%	110,339 $147,000
Q2 2019 Aug 13, 2019	BUY	$1.37 - $2.02 $909 - $1,341	664 Added 0.61%	109,983 $155,000
Q1 2019 May 06, 2019	SELL	$1.01 - $1.83 $1,911 - $3,464	-1,893 Reduced 1.7%	109,319 $181,000
Q4 2018 Feb 13, 2019	SELL	$0.98 - $1.85 $836 - $1,579	-854 Reduced 0.76%	111,212 $111,000
Q3 2018 Nov 09, 2018	BUY	$1.76 - $6.38 $14,673 - $53,190	8,337 Added 8.04%	112,066 $197,000
Q2 2018 Aug 08, 2018	BUY	$3.29 - $4.82 $28,586 - $41,880	8,689 Added 9.14%	103,729 $356,000
Q1 2018 May 07, 2018	SELL	$1.81 - $5.98 $9,250 - $30,563	-5,111 Reduced 5.1%	95,040 $404,000
Q4 2017 Feb 09, 2018	BUY	$1.8 - $2.32 $849 - $1,095	472 Added 0.47%	100,151 $180,000
Q3 2017 Nov 09, 2017	BUY	$1.99 - $2.65 $198,361 - $264,149	99,679	99,679 $217,000

Others Institutions Holding GERN

# of Institutions

248

Shares Held

374M

Call Options Held

1.48M

Put Options Held

1.18M

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.6B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Geron Corp Transaction History